Yuriko Shimizu
7PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 26, 2025
Association Between CKAP4 Expression and Poor Prognosis in Patients with Bladder Cancer Treated with Radical Cystectomy.Hiroki Katsumata, Dai Koguchi, Shuhei Hirano
|Oct 14, 2023
Membranous Expression of Heart Development Protein with EGF-like Domain 1 Is Associated with a Good Prognosis in Patients with Bladder Cancer.Kohei Mori, Kazumasa Matsumoto, Masaomi Ikeda
|Oct 14, 2023
Expression of S100A16 Is Associated with Biological Aggressiveness and Poor Prognosis in Patients with Bladder Cancer Who Underwent Radical Cystectomy.Hiroki Katsumata, Kazumasa Matsumoto, Kengo Yanagita
|Oct 27, 2022
Gemcitabine-Paclitaxel Chemotherapy for Patients with Advanced Urothelial Cancer Refractory to Cisplatin-Based Chemotherapy: Predictive Role of PGK1 for Treatment Response to Cytotoxic Chemotherapy.Dai Koguchi, Kazumasa Matsumoto, Masaomi Ikeda
|May 28, 2022
DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer.Shuhei Hirano, Kazumasa Matsumoto, Kei Tanaka
|Mar 25, 2022
Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer.Kohei Mori, Kazumasa Matsumoto, Noriyuki Amano
Pageof 2
